New York City, NY -- (SBWIRE) -- 01/07/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA), Biozone Pharmaceuticals Inc (OTCBB:BZNE), Bio-Path Holdings Inc (OTCMKTS:BPTH), Naturalnano Inc (OTCMKTS:NNAN)
Federal National Mortgage Assctn Fnni Me (OTCBB:FNMA) declined -4.07%, trading on 12.67 million shares, to end the trade at $2.83. The stock changed hands in a range of $2.79 to $2.95, bringing its market capitalization to about $3.28 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.26 and was moved to the maximum level of $5.44. Federal National Mortgage Association Fannie Mae is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage-related assets are purchased and sold.
Why Should Investors Buy FNMA After the Recent Fall? Just Go Here and Find Out
Biozone Pharmaceuticals Inc (OTCBB:BZNE) declined -4.41%, to complete the trading session at $0.650, with a total volume of 1.18 million shares. The stock, on average, trades on a volume of 717,774 shares. It floated in a range of $0.65 to $0.70 during the last trading session, with a beta value of -39.56. Its market capitalization now moved to about $45.25 million. In the past 52 weeks, the share price has not declined below $0.16 and above $3.75. Biozone Pharmaceuticals, Inc. (Biozone Pharma), formerly International Surf Resorts, Inc., through its wholly owned subsidiary, BioZone Laboratories, Inc. (Biozone Labs), primarily is engaged in the business of developing and manufacturing over the counter (OTC) drug products and cosmetic and beauty products on behalf of third parties. In addition, through its wholly owned subsidiaries, Equalan LLC (Equalan) and Baker Cummins Corp.
Will BZNE Get Buyers Even After The Recent Rally? Find Out Here
Bio-Path Holdings Inc (OTCMKTS:BPTH) recorded a fall of -4.91% and was in a range of $4.50-$4.99 before closing at $4.65. The stock completed the day with a total volume of 192,323 shares, versus an average volume of 68,969 shares. The share price hit its 52-week low of $0.30 and $5.25 was the best price. Bio-Path Holdings Inc is a development stage company. The Company, through its wholly owned subsidiary, Bio-Path, Inc. is engaged in the business of developing cancer therapeutics. As of December 31, 2011, the Company had licenses from The University of Texas M. D. Anderson Cancer Center (MD Anderson) for three lead products and nucleic acid delivery technology, including tumor targeting technology.
Will BPTH Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Naturalnano Inc (OTCMKTS:NNAN) declined -5.51% yesterday, bringing its market capitalization around $3.84 million. The share price, after opening at $0.01, made a high of $0.01 and hovered above $0.01 to end the day at $0.0120. The total number of shares that changed hands during the session was 13.39 million shares, as compared to average trading volume of 7.54 million shares. NaturalNano, Inc. (NaturalNano) is engaged in the development and commercialization of material science technologies with an emphasis on additives to polymers and other industrial and consumer products by taking advantage of technology advances developed in-house.
Is it the Right to Grab NNAN after the Recent Slump? Get Free Trend Analysis Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)